Longboard Pharmaceuticals Investor Relations Material
Latest events
Q2 2024
Longboard Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Longboard Pharmaceuticals Inc
Access all reports
Longboard Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company primarily focused on developing innovative therapies for neurological diseases. Leveraging its expertise in G protein-coupled receptor (GPCR) technology, Longboard Pharmaceuticals aims to create transformative treatments for these conditions. The company's product candidates are designed to be highly selective with the potential to offer significant improvements over existing therapies. Notably, the company was founded as a spin-off from Arena Pharmaceuticals in 2020 to further advance these specialized drug candidates. The company is headquartered in La Jolla, California, and its shares are listed on the NASDAQ.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
LBPH
Country
πΊπΈ United States